Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
French study finds taking meds for four days with three days off is as effective as daily therapy—and costs 43% less.
Doctors attribute the drop to increased testing and U=U.
People living with HIV are also facing cancer as they age.
The Food and Drug Administration has approved a new treatment for people living with HIV.
A recent review of 54 studies indicates that people living with HIV are at high risk for experiencing cardiac dysfunction.
A clinical trial has confirmed that new HIV treatment Trogarzo suppresses one’s viral load.
The increasing mastery over the virus is one of humanity’s crowning achievements.
This quick-reference chart compares available antiretroviral (ARV) medication options, including adult dosing and dietary restrictions.
The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.
Final results from the PARTNER 2 study of gay and bi men confirm that undetectable equals untransmittable.
A study finds that CD4 cells decline after people with HIV contract hepatitis C.
Treatment efficacy has steadily improved since effective combination HIV therapy first entered advanced clinical trials in the mid-1990s.
A look at 2009 to 2014 data found that those in care for HIV saw a considerable fall in treatment deferrals.
More than 250,000 people living with HIV would be affected by a proposed rule change to Medicare Part D.
Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.
Periodic infusions of long-acting HIV antibodies may eventually become a new way of treating the virus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.